Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Anthrax test kits

This article was originally published in The Tan Sheet

Executive Summary

Columbus, Ohio-based Toxicology Associates is barred from selling, advertising anthrax nasal swab test kits to Pennsylvania residents under a state court judge's Nov. 18 order. Firm, which sells the $65 kits through its Web site, 1toxassociates.com, also must pay restitution to commonwealth consumers who purchased the anthrax test kits and request a refund through AG's office by Feb. 13, and must pay $5,000 in civil penalties, $2,265 in litigation costs. In an April complaint, AG alleged company violated Unfair Trade Practices & Consumer Protection Law by representing that its tests can determine whether consumers have contracted anthrax. Commonwealth points to CDC guidelines that state nasal swab cultures should not be used to diagnose anthrax; AG also notes firm is not a federally certified facility that can positively confirm presence of anthrax. Company did not file an answer to the lawsuit, AG's office says...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel